Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Percheron Therapeutics

    MCap

    AUD8m

    Last close

    AUD0.00

    ▲ 0.00 (33.33%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    Funding Circle

    MCap

    GBP685m

    Last close

    GBP2.50

    ▲ 16.00 (6.84%)

  • Sectors

    Sectors

    View All Sectors
  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Oxford Biomedica (LSE: OXB)

Last close As at 11/11/2026

—

— 0.00 (0.00%)

Market capitalisation

—

Oxford Biomedica is a UK-based company with a leading position in cancer immunotherapy and gene-based products. It is focusing its efforts on two clinical programmes, ProSavin and TroVax, and has an ocular collaboration with Sanofi-Aventis.

Latest Insights

View More

Healthcare | Comment

Oxford Biomedica (LSE: OXB) revenues surge 44% 

Healthcare | Flash note

Oxford Biomedica — COVID vaccine and Kymriah news encouraging

Healthcare | edison tv

Oxford Biomedica: Edison Open House Healthcare 2022

Healthcare | Outlook

Oxford Biomedica — Driving innovation in a thriving CGT industry

Market Data

Share Price —
Market Cap —
52-Week High —
52-Week Low —
% Change 1M
% Change 6M —
% Change 12M
Ave. Daily Volume 1yr —
Visit Website

Sector

Healthcare